公开(公告)号：US20230123729A1

公开(公告)日：2023-04-20

申请号：US17732631

申请日：2022-04-29

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： C07D413/04 ,  C07D413/14 ,  A61K31/397 ,  A61K31/4025 ,  A61K31/4178 ,  A61K31/4453 ,  A61K31/496 ,  A61P25/28 ,  A61K31/422 ,  A61K45/00

摘要： Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.

公开(公告)号：US20200276167A1

公开(公告)日：2020-09-03

申请号：US16646744

申请日：2018-09-17

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： A61K31/422 ,  A61K31/496 ,  A61K31/4545 ,  A61P25/00

摘要： Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.

公开(公告)号：US20180201608A1

公开(公告)日：2018-07-19

申请号：US15786772

申请日：2017-10-18

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： C07D413/04 ,  A61K31/4025 ,  A61K31/397 ,  A61K31/422 ,  C07D413/14 ,  A61K31/4178 ,  A61K31/4453 ,  A61K31/496 ,  A61K45/00

CPC分类号： C07D413/04 ,  A61K31/397 ,  A61K31/4025 ,  A61K31/4178 ,  A61K31/422 ,  A61K31/4453 ,  A61K31/496 ,  A61K45/00 ,  A61P25/28 ,  C07D413/14

摘要： Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.

公开(公告)号：US20170174670A1

公开(公告)日：2017-06-22

申请号：US15129190

申请日：2015-03-27

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： C07D413/04 ,  A61K31/422 ,  C07D413/14

CPC分类号： C07D413/04 ,  A61K31/397 ,  A61K31/4025 ,  A61K31/4178 ,  A61K31/422 ,  A61K31/4453 ,  A61K31/496 ,  A61K45/00 ,  A61P25/28 ,  C07D413/14

摘要： Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.

公开(公告)号：US20240115553A1

公开(公告)日：2024-04-11

申请号：US18135225

申请日：2023-04-17

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： A61K31/422 ,  A61K31/4545 ,  A61K31/496 ,  A61P25/00

CPC分类号： A61K31/422 ,  A61K31/4545 ,  A61K31/496 ,  A61P25/00

摘要： Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.

公开(公告)号：US20190099410A1

公开(公告)日：2019-04-04

申请号：US15987053

申请日：2018-05-23

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： A61K31/4545 ,  C07D413/14 ,  A61K31/5377 ,  A61K31/496 ,  C07D413/04 ,  A61K31/439 ,  A61K31/422 ,  A61K31/4178 ,  A61K31/397 ,  A61K31/454

摘要： Compounds and compositions are described herein for treating post traumatic stress disorder.

公开(公告)号：US20160339006A1

公开(公告)日：2016-11-24

申请号：US15134549

申请日：2016-04-21

申请人： Azevan Pharmaceuticals, Inc.

发明人： Michael J. BROWNSTEIN

IPC分类号： A61K31/4545 ,  C07D413/04 ,  A61K31/439 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5377 ,  C07D413/14 ,  A61K31/422

CPC分类号： A61K31/4545 ,  A61K31/397 ,  A61K31/4178 ,  A61K31/422 ,  A61K31/439 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5377 ,  C07D413/04 ,  C07D413/14

摘要： Compounds and compositions are described herein for treating post traumatic stress disorder.